Sarah Lynam

531 total citations
13 papers, 394 citations indexed

About

Sarah Lynam is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Sarah Lynam has authored 13 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Immunology. Recurrent topics in Sarah Lynam's work include Ovarian cancer diagnosis and treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune Cell Function and Interaction (2 papers). Sarah Lynam is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Immune Cell Function and Interaction (2 papers). Sarah Lynam collaborates with scholars based in United States, United Kingdom and India. Sarah Lynam's co-authors include Kunle Odunsi, Suzanne L. Dickson, David Sunter, Emese Zsíros, Stacey N. Akers, Peter J. Frederick, Shashikant Lele, Eduardo Cortes Gomez, Shanmuga Reddy Chilakapati and Kristopher Attwood and has published in prestigious journals such as Gynecologic Oncology, Neuroscience Letters and JAMA Oncology.

In The Last Decade

Sarah Lynam

12 papers receiving 388 citations

Peers

Sarah Lynam
Carl-Gustaf Nilsson Finland
Marı́a Gabriela Ballerini Argentina
Zachary Nash United Kingdom
Ruth Y. Peng United States
İbrahim Şahin Türkiye
Fabien Guimiot France
Yongchao Lu China
Sachiko Morioka Japan
Shanshan Jia China
Ghassan Haddad United States
Carl-Gustaf Nilsson Finland
Sarah Lynam
Citations per year, relative to Sarah Lynam Sarah Lynam (= 1×) peers Carl-Gustaf Nilsson

Countries citing papers authored by Sarah Lynam

Since Specialization
Citations

This map shows the geographic impact of Sarah Lynam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Lynam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Lynam more than expected).

Fields of papers citing papers by Sarah Lynam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Lynam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Lynam. The network helps show where Sarah Lynam may publish in the future.

Co-authorship network of co-authors of Sarah Lynam

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Lynam. A scholar is included among the top collaborators of Sarah Lynam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Lynam. Sarah Lynam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yeku, Oladapo, Minal Barve, Winston Tan, et al.. (2025). Myeloid targeting antibodies PY159 and PY314 for platinum-resistant ovarian cancer. Journal for ImmunoTherapy of Cancer. 13(3). e010959–e010959. 6 indexed citations
2.
Chapman, Graham, et al.. (2023). Gynecologic cancer care in the first year of the COVID-19 pandemic. Gynecologic Oncology. 178. 138–144. 1 indexed citations
3.
Zsíros, Emese, Sarah Lynam, Kristopher Attwood, et al.. (2020). Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer. JAMA Oncology. 7(1). 78–78. 142 indexed citations
4.
Lynam, Sarah, Kayla Morrell, Kevin H. Eng, et al.. (2019). Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service. PubMed. 1(3). 1–5. 4 indexed citations
5.
Lynam, Sarah, Paul Mayor, Kevin H. Eng, et al.. (2019). Breaking the silence: Burnout among gynecologic oncology trainees is an impending crisis. Gynecologic Oncology. 154. 9–10. 1 indexed citations
6.
Lynam, Sarah, Amit A. Lugade, & Kunle Odunsi. (2019). Immunotherapy for Gynecologic Cancer: Current Applications and Future Directions. Clinical Obstetrics & Gynecology. 63(1). 48–63. 30 indexed citations
7.
Lynam, Sarah, Paul Mayor, Kristen Starbuck, et al.. (2019). Unfitness and cancer: State-of-the-art activity tracking devices reveal the unexpectedly sedentary lives of our cancer patients. Gynecologic Oncology. 154. 194–194.
8.
Mayor, Paul, Stacey N. Akers, Shashikant Lele, et al.. (2019). Surgery induces broad changes in clinically relevant genes regulating immune and metabolic responses in murine epithelial ovarian cancer. Gynecologic Oncology. 154. 36–36. 2 indexed citations
9.
Morrell, Kayla, Kevin H. Eng, Alan D. Hutson, et al.. (2018). Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery. JAMA Network Open. 1(8). e185452–e185452. 88 indexed citations
10.
Díaz-Montes, Teresa, Sarah Lynam, Michelle Sittig, et al.. (2018). Efficacy of Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Treatment of Recurrent Uterine Sarcoma. International Journal of Gynecological Cancer. 28(6). 1130–1137. 22 indexed citations
11.
Lynam, Sarah, Katrina Mark, & Sarah M. Temkin. (2016). Primary Placement of Incisional Negative Pressure Wound Therapy at Time of Laparotomy for Gynecologic Malignancies. International Journal of Gynecological Cancer. 26(8). 1525–1529. 14 indexed citations
12.
Lynam, Sarah, et al.. (2015). Risk, Risk Reduction and Management of Occult Malignancy Diagnosed after Uterine Morcellation: A Commentary. Women s Health. 11(6). 929–944. 5 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl-Gustaf Nilsson Breakdown of academic impact, for papers by Marı́a Gabriela Ballerini Breakdown of academic impact, for papers by Zachary Nash Breakdown of academic impact, for papers by Ruth Y. Peng Breakdown of academic impact, for papers by İbrahim Şahin Breakdown of academic impact, for papers by Fabien Guimiot Breakdown of academic impact, for papers by Yongchao Lu Breakdown of academic impact, for papers by Sachiko Morioka Breakdown of academic impact, for papers by Shanshan Jia Breakdown of academic impact, for papers by Ghassan Haddad
Rankless by CCL
2026